Cargando…
Cocaine Use Disorder (CUD): Current Clinical Perspectives
Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and society. Individuals with CUD face many barriers in accessing treatment for CUD, and most individuals with CUD never receive treatment. In this review, we provide an overview of CUD, including risk factors for CUD,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451050/ https://www.ncbi.nlm.nih.gov/pubmed/36093428 http://dx.doi.org/10.2147/SAR.S337338 |
_version_ | 1784784653418233856 |
---|---|
author | Schwartz, Elizabeth K C Wolkowicz, Noah R De Aquino, Joao P MacLean, R Ross Sofuoglu, Mehmet |
author_facet | Schwartz, Elizabeth K C Wolkowicz, Noah R De Aquino, Joao P MacLean, R Ross Sofuoglu, Mehmet |
author_sort | Schwartz, Elizabeth K C |
collection | PubMed |
description | Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and society. Individuals with CUD face many barriers in accessing treatment for CUD, and most individuals with CUD never receive treatment. In this review, we provide an overview of CUD, including risk factors for CUD, common co-occurring disorders, acute and chronic effects of cocaine use, and currently available pharmacological and behavioral treatments. There are no FDA-approved pharmacological treatments for CUD. Future studies with larger sample sizes and testing treatment combinations are warranted. However, individuals with CUD and co-occurring disorders (eg, a mood or anxiety disorder) may benefit from medication treatments. There are behavioral interventions that have demonstrated efficacy in treating CUD – contingency management (CM) and cognitive-behavioral therapy for substance use disorders (CBT-SUD) in particular – however many barriers remain in delivering these treatments to patients. Following the discussion of current treatments, we highlight some promising emerging treatments, as well as offer a framework that can be used in building a treatment plan for individuals with CUD. |
format | Online Article Text |
id | pubmed-9451050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-94510502022-09-08 Cocaine Use Disorder (CUD): Current Clinical Perspectives Schwartz, Elizabeth K C Wolkowicz, Noah R De Aquino, Joao P MacLean, R Ross Sofuoglu, Mehmet Subst Abuse Rehabil Review Cocaine use disorder (CUD) is a devastating disorder, impacting both individuals and society. Individuals with CUD face many barriers in accessing treatment for CUD, and most individuals with CUD never receive treatment. In this review, we provide an overview of CUD, including risk factors for CUD, common co-occurring disorders, acute and chronic effects of cocaine use, and currently available pharmacological and behavioral treatments. There are no FDA-approved pharmacological treatments for CUD. Future studies with larger sample sizes and testing treatment combinations are warranted. However, individuals with CUD and co-occurring disorders (eg, a mood or anxiety disorder) may benefit from medication treatments. There are behavioral interventions that have demonstrated efficacy in treating CUD – contingency management (CM) and cognitive-behavioral therapy for substance use disorders (CBT-SUD) in particular – however many barriers remain in delivering these treatments to patients. Following the discussion of current treatments, we highlight some promising emerging treatments, as well as offer a framework that can be used in building a treatment plan for individuals with CUD. Dove 2022-09-03 /pmc/articles/PMC9451050/ /pubmed/36093428 http://dx.doi.org/10.2147/SAR.S337338 Text en © 2022 Schwartz et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Schwartz, Elizabeth K C Wolkowicz, Noah R De Aquino, Joao P MacLean, R Ross Sofuoglu, Mehmet Cocaine Use Disorder (CUD): Current Clinical Perspectives |
title | Cocaine Use Disorder (CUD): Current Clinical Perspectives |
title_full | Cocaine Use Disorder (CUD): Current Clinical Perspectives |
title_fullStr | Cocaine Use Disorder (CUD): Current Clinical Perspectives |
title_full_unstemmed | Cocaine Use Disorder (CUD): Current Clinical Perspectives |
title_short | Cocaine Use Disorder (CUD): Current Clinical Perspectives |
title_sort | cocaine use disorder (cud): current clinical perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451050/ https://www.ncbi.nlm.nih.gov/pubmed/36093428 http://dx.doi.org/10.2147/SAR.S337338 |
work_keys_str_mv | AT schwartzelizabethkc cocaineusedisordercudcurrentclinicalperspectives AT wolkowicznoahr cocaineusedisordercudcurrentclinicalperspectives AT deaquinojoaop cocaineusedisordercudcurrentclinicalperspectives AT macleanrross cocaineusedisordercudcurrentclinicalperspectives AT sofuoglumehmet cocaineusedisordercudcurrentclinicalperspectives |